Funding for this research was provided by:
China Hepatitis Prevention and Treatment Foundation - China HBV Prevention and Control Research Fund (YGFK20190092)
Article History
Received: 22 August 2025
Accepted: 15 December 2025
First Online: 20 December 2025
Declarations
:
: The study was approved by the Scientific Research Ethics Review Committee of the Taiyuan Center for Disease Control and Prevention (Approval No. 2020001; approved on October 15, 2020). Prior to participation, written informed consent was obtained from all individual participants. The study adhered to the principles of the Declaration of Helsinki and followed national guidelines for biomedical research involving human participants.
: Not applicable.
: The authors declare no competing interests.